• support@madhedgefundtrader.com
  • Member Login
Mad Hedge Fund Trader
  • Home
  • About
  • Store
  • Luncheons
  • Testimonials
  • Contact Us
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu
april@madhedgefundtrader.com

About april@madhedgefundtrader.com

This author has not written his bio yet.
But we are proud to say that april@madhedgefundtrader.com contributed 3306 entries already.

Entries by april@madhedgefundtrader.com

Diary, Newsletter, Summary

December 15, 2023

Global Market Comments December 15, 2023 Fiat Lux Featured Trade: (DECEMBER 13 BIWEEKLY STRATEGY WEBINAR Q&A), (BYDDF), (TSLA), (NEM), (UNG), (WMT), (TGT), (GOLD), (TLT), (JNK), (HYG)

Diary, Newsletter

December 13 Biweekly Strategy Webinar Q&A

Below please find subscribers’ Q&A for the December 13 Mad Hedge Fund Trader Global Strategy Webinar, broadcast from Silicon Valley, CA. Q: I think it's a good time to buy gold, do you agree? If so, what are your top picks for a long-term hold? A: I was looking at some very long-term gold charts,

Trade Alert

Trade Alert - (NLY) December 15, 2023 - EXPIRATION AT MAX PROFIT

When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline.

Trade Alert

Trade Alert - (CAT) December 15, 2023 - EXPIRATION AT MAX PROFIT

When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline.

Biotech Letter

December 14, 2023

Mad Hedge Biotech and Healthcare Letter December 14, 2023 Fiat Lux Featured Trade: (EDITING YOUR PORTFOLIO) (CRSP), (VRTX), (BLUE), (BEAM), (CRBU), (EDIT), (NTLA), (PRME), (VERV), (LLY), (REGN)

Biotech Letter

Editing Your Portfolio

In the world of biotechnology, the buzz these days is all about gene editing – a frontier that’s moving at warp speed. While the journey from sequencing the first human genome took a staggering 13 years, companies like CRISPR Therapeutics (CRSP) have sped up the process, bringing their revolutionary "molecular scissors" concept to market in

Tech Alert

Tech Alert - (PANW) December 14, 2023 - TAKE PROFITS - SELL

When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline.

Diary, Newsletter, Summary

December 14, 2023

Global Market Comments December 14, 2023 Fiat Lux Featured Trade: (JACQUIE MUNRO JANUARY 10, 2024 MELBOURNE AUSTRALIA STRATEGY LUNCHEON), (TESTIMONIAL), (A DAY WITH TOM FRIEDMAN OF THE NEW YORK TIMES)

Tech Letter

December 13, 2023

Mad Hedge Technology Letter December 13, 2023 Fiat Lux Featured Trade: (RIVIAN SPEEDS UP) (RIVN), (TSLA)

Tech Letter

Rivian Speeds Up

One company I am quite bullish on is EV maker Rivian (RIVN). They make great cars, but they also lose money by the fistful. How bad is it? Rivian lost $1.19 a share in Q3, less than feared, while revenue jumped 149% $1.34 billion. The EV startup produced 16,304 vehicles and delivered 15,564 vehicles in

Page 213 of 246«‹211212213214215›»

Legal Disclaimer

There is a very high degree of risk involved in trading. Past results are not indicative of future returns. MadHedgeFundTrader.com and all individuals affiliated with this site assume no responsibilities for your trading and investment results. The indicators, strategies, columns, articles and all other features are for educational purposes only and should not be construed as investment advice. Information for futures trading observations are obtained from sources believed to be reliable, but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. Your use of the trading observations is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness of the information. You must assess the risk of any trade with your broker and make your own independent decisions regarding any securities mentioned herein. Affiliates of MadHedgeFundTrader.com may have a position or effect transactions in the securities described herein (or options thereon) and/or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies.

Copyright © 2026. Mad Hedge Fund Trader. All Rights Reserved. support@madhedgefundtrader.com
Scroll to top